Health
Changxing Island accelerates development of world-class green petrochemical industrial base
BEIJING, Oct. 30, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn:
World Stroke Congress | TASTE-2 significantly reduces stroke disability
NANJING, China, Oct. 30, 2024 /PRNewswire/ -- Oct 24th 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that a new clinical study with major clinical findings regarding Sanbexin (edaravone and dexborneol concentrated solution for injection) has been published at the 16th World Stroke...
Teijin and Hilleman Laboratories to Expand Business in Asia-Pacific via Strategic Partnership to Promote CDMO Services in Cell and Gene Therapy
SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- Teijin Limited
Ban Ki-moon Calls for Global Unity in Pursuit of Sustainable Development at 2024 ESG Global Leaders Conference
SHANGHAI, Oct. 30, 2024 /PRNewswire/ -- The 2024 ESG Global Leaders Conference was held inShanghai from October 16th to 18th. Ban Ki-moon, Former Secretary-General of the United Nations, Chairman of the Boao Forum forAsia, attended and delivered a closing remarks. The 2024 ESG Global Leaders Con...
Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care
RAMAT GAN, Israel, Oct. 30, 2024 /PRNewswire/ -- Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next five years, Pulsenmore will sup...
Philips Massager Singapore Marks a Milestone as Support Sponsor at Garmin Run Singapore 2024
SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- Philips Massager, a new category within the Royal Philips group, proudly participated as the support sponsor for the Garmin Run Singapore 2024, which took place onOctober 13 at the scenic Marina Barrage. This collaboration marked a significant milestone fo...
Fosun Pharma Announces 2024Q3 Financial Results
Revenue Exceed RMB30.9 Billion with R&D Expenditure RMB3.9 Billion Continuing to Consolidate its Dominant Position In The fields of Breast Cancer and Lung Cancer SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- On October 29, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group";...
Hot from Hong Kong Fintech Week 2024: AI's Role in Transforming Insurance
SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- At the 2024 Hong Kong FinTech Week InsurTech Forum,Charles Hung, CEO of Blue Insurance; Gilbert Leung, CEO of Novo AI; andPriscilla Ng, Prudential's Group Chief Customer & Marketing Officer explored the transformative role of AI in the insurance sector. Th...
WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year
SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has been awarded the 2024 Global CRDMO Company of the Year Award by Frost & Sullivan, a gr...
Celltrion presents post hoc analysis of LIBERTY studies of ZYMFENTRA® (infliximab-dyyb) at the American College of Gastroenterology 2024 Annual Scientific Meeting
* Pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) previously demonstrated superior efficacy of subcutaneous (SC) infliximab over placebo for maintenance therapy in patients with Crohn's disease (CD) and ulcerative colitis (UC)[1], [2] * ZYMFENTRA® is the first and only FDA-approved subcut...
I Peace announces new iPSC lines to reduce immune rejection risk for U.S. population
More than 100 million people in the US have this HLA-A haplotype
PALO ALTO, Calif., Oct. 29, 2024 /PRNewswire/ -- Leading GMP cell CDMO I
Peace, Inc. (https://www.ipeace.com
LILYSILK Continues Partnership with National Breast Cancer Foundation for Breast Cancer Awareness Month
NEW YORK, Oct. 29, 2024 /PRNewswire/ -- LILYSILK
CAS introduces stereoselective labeling in the CAS SciFinder® retrosynthesis tool - a first-of-its-kind capability in the world of scientific technology solutions
The new capability combines the industry-leading CAS Content Collection™ with cutting-edge technology and enables scientists to innovate with confidence COLUMBUS, Ohio, Oct. 29, 2024 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, ...
Complete Genomics integrates NVIDIA Parabricks to offer researchers faster, more cost-effective and accurate genomic sequencing analysis
Complete Genomics DNBSEQ data and NVIDIA Parabricks yield deeper insights into genetic variants with deep learning SAN JOSE, Calif., Oct. 29, 2024 /PRNewswire/ -- Complete Genomics today announced an integration of its next-generation sequencing (NGS) DNBSEQ platforms* with NVIDIA Parabricks sof...
DeepQure Presents Clinical Results of Laparoscopic RDN at TCT 2024, Demonstrating Cutting-edge Technology and Innovation
SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- DeepQure, a global pioneer in resistant hypertension treatment, has unveiled clinical results of its laparoscopic renal denervation (RDN) medical device "HyperQure". Designed to treat resistant hypertension,HyperQure uses a laparoscopic approach t...
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
GAITHERSBURG, Md., Oct. 29, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for i...
Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd.
CHENGDU, China, Oct. 29, 2024 /PRNewswire/ -- Qilian International Holding Group Ltd. ("Qilian" or the "Company") (NASDAQ: BGM) is pleased to announce that effective onOctober 30, 2024, the Company will change its name to "BGM Group Ltd." In connection with the name change, the trading symbol of ...
GemVax Announces Topline Results from Phase 2a Progressive Supranuclear Palsy Clinical Trial at Neuro2024
- Topline supports moving to Phase 3 trial and shows potential to develop GV1001 as the world's first PSP treatment SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ ticker: 082270) announced that topline results of a Phase 2a clinical trial (the ...
Discovery of cancer risk associations for six novel genes
REYKJAVIK, Iceland, Oct. 29, 2024 /PRNewswire/ --Scientists at deCODE genetics/Amgen, and their collaborators have discovered six novel genes with rare germline variants that associate with cancer risk. The findings are published today in Nature Genetics under the title "Gene-based burden tests o...
Regional and Global Experts Convene in Accra, Ghana to Update Cancer Treatment Guidelines for Sub-Saharan Africa
Ongoing international oncology collaboration works to empower health care workers and save lives across diverse resource environments. Accra, GHANA, Oct. 29, 2024 /PRNewswire/ -- International oncology experts are gathering inAccra, Ghana for a series of meetings beginning today, to update cance...
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 312 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 296 media titles]
2024-11-15 15:25